
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Selvedge Venture is a venture capital firm founded by Alasdair Thong and Robert Thong, dedicated to alleviating healthcare burdens associated with age-related medical conditions. Established in the United States, the firm focuses on early-stage investments, specifically in Pre-Seed, Seed, and Series A rounds. The organization has made a total of 16 investments across 10 portfolio companies, demonstrating its commitment to supporting innovative startups in the healthcare sector.
Selvedge Venture operates at the intersection of biotechnology and digital technologies, aiming to enhance patient outcomes through advancements in these fields. The firm has established a notable presence in the healthcare investment landscape, particularly in addressing age-related medical conditions. Its strategic focus on this niche aligns with demographic trends and the growing need for innovative healthcare solutions.
Selvedge Venture invests in startups that tackle three primary age-related medical conditions: Metabolic Syndrome, Cancer, and Neurodegenerative Diseases. Metabolic Syndrome encompasses Cardiovascular Disease, Diabetes, Fatty Liver Disease, and Obesity. The firm seeks innovations that can improve diagnostics and treatment in these areas, leveraging advancements in biotechnology and digital technologies.
The organization is particularly interested in early-stage companies that demonstrate a clear mission to alleviate the healthcare burden caused by these conditions. Selvedge Venture typically invests in Pre-Seed, Seed, and Series A stages, with an average round size of approximately $6 million. The firm emphasizes the importance of founders who are committed to making a significant impact in the healthcare sector.
Selvedge Venture's portfolio includes notable companies that are making strides in healthcare innovation:
These companies exemplify Selvedge Venture's commitment to investing in innovative solutions that address critical healthcare challenges associated with aging.
Alasdair Thong: Founding Partner at Selvedge Venture, Alasdair has a background in biotechnology and healthcare investments. He has been instrumental in shaping the firm's investment strategy and focus on age-related medical conditions.
Robert Thong: Co-Founder & General Partner, Robert brings extensive experience in venture capital and a deep understanding of the healthcare landscape. His expertise lies in identifying innovative startups that align with Selvedge Venture's mission.
Esra Berkol: Chief of Staff, Esra plays a crucial role in supporting the firm's operations and portfolio management. Her background includes experience in healthcare startups and strategic planning.
To pitch Selvedge Venture, founders should visit their website at selvedgeventure.com. The firm prefers pitches that include a clear overview of the startup's mission, the problem being addressed, and the innovative solution being offered. Founders should also provide insights into the market opportunity and competitive landscape.
While there is no specific application form mentioned, a well-structured pitch deck is essential. Founders should expect a response time that varies based on the volume of submissions, but timely follow-ups are encouraged.
As of October 2023, Selvedge Venture has made 16 investments across 10 portfolio companies, focusing on innovative solutions in healthcare. The firm continues to seek opportunities in the biotechnology and digital technology sectors, particularly those addressing age-related medical conditions.
Recent activity includes ongoing support for portfolio companies such as Kytopen, Sanome, and Yuri, which are making significant advancements in their respective fields. Selvedge Venture remains committed to enhancing patient outcomes through strategic investments and partnerships.
What are Selvedge Venture's investment criteria?
Selvedge Venture focuses on early-stage companies addressing age-related medical conditions, particularly in the sectors of biotechnology, healthcare, and AI. They look for startups that demonstrate a clear mission to alleviate healthcare burdens and have innovative solutions in areas such as Metabolic Syndrome, Cancer, and Neurodegenerative Diseases.
How can founders apply or pitch to Selvedge Venture?
Founders can pitch their ideas by visiting Selvedge Venture's website at selvedgeventure.com. The firm encourages startups to present their innovations and how they align with the firm's focus on age-related healthcare solutions.
What makes Selvedge Venture different from other investors?
Selvedge Venture distinguishes itself by concentrating specifically on age-related medical conditions and leveraging advancements in biotechnology and digital technologies. Their expertise in these areas allows them to provide strategic support to portfolio companies, helping them navigate the complexities of the healthcare landscape.
What is the geographic scope of Selvedge Venture's investments?
Selvedge Venture primarily invests in companies based in the United States, focusing on startups that are innovating in the healthcare and biotech sectors.
What is the typical check size for investments?
Selvedge Venture typically invests in rounds averaging around $6 million, targeting early-stage companies in Pre-Seed, Seed, and Series A stages.
What kind of post-investment involvement does Selvedge Venture have?
Selvedge Venture provides strategic support to its portfolio companies, leveraging its expertise in biotechnology and digital technologies to help them grow and succeed in the healthcare market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.